Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Phase 2 study Inquiry

<< Previous

Bullboard Posts

Next >>

Comment by skys1on Jan 11, 2021 4:59am

134 Views

Post# 32265192

RE:RE:RE:RE:RE:Phase 2 study Inquiry

Agree Yajne, For tarmarindo1 to bring up the entire negative episode in such detail indicates he must have some type of axe to grind.
Very little history, but claims to be a very long time share holder. My guess is probably a paid basher. iggy is a good option.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing